Weiling Leng

441 total citations
19 papers, 351 citations indexed

About

Weiling Leng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Weiling Leng has authored 19 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Weiling Leng's work include Cardiovascular Function and Risk Factors (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Weiling Leng is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Weiling Leng collaborates with scholars based in China and United States. Weiling Leng's co-authors include Ziwen Liang, Liu Chen, Qinan Wu, Xinshou Ouyang, Wuquan Deng, Bing Chen, Jian Wang, Xiaochun Zhang, Zhihui Zhang and Qi Yang and has published in prestigious journals such as Molecular and Cellular Endocrinology, Mediators of Inflammation and Annals of Translational Medicine.

In The Last Decade

Weiling Leng

18 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiling Leng China 9 197 125 109 67 43 19 351
Weiheng Wen China 7 106 0.5× 167 1.3× 71 0.7× 58 0.9× 59 1.4× 15 380
Lamia Amoura France 8 102 0.5× 123 1.0× 56 0.5× 56 0.8× 23 0.5× 16 311
Ching Fai Kwok Taiwan 12 179 0.9× 125 1.0× 106 1.0× 124 1.9× 112 2.6× 21 496
Elisabetta Nardella Italy 13 64 0.3× 82 0.7× 196 1.8× 70 1.0× 62 1.4× 24 395
Alana Aragón‐Herrera Spain 10 135 0.7× 104 0.8× 111 1.0× 107 1.6× 77 1.8× 26 391
Miguel Ángel Gómez-Sámano Mexico 9 102 0.5× 122 1.0× 52 0.5× 24 0.4× 75 1.7× 23 311
Can Pang China 9 97 0.5× 71 0.6× 67 0.6× 70 1.0× 135 3.1× 14 414
Marissa Lightbourne United States 9 85 0.4× 91 0.7× 112 1.0× 44 0.7× 54 1.3× 20 297
Fang‐Hong Shi China 12 152 0.8× 112 0.9× 43 0.4× 44 0.7× 29 0.7× 31 307
Min Ho Cho South Korea 10 124 0.6× 69 0.6× 67 0.6× 82 1.2× 85 2.0× 25 355

Countries citing papers authored by Weiling Leng

Since Specialization
Citations

This map shows the geographic impact of Weiling Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling Leng more than expected).

Fields of papers citing papers by Weiling Leng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiling Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling Leng. The network helps show where Weiling Leng may publish in the future.

Co-authorship network of co-authors of Weiling Leng

This figure shows the co-authorship network connecting the top 25 collaborators of Weiling Leng. A scholar is included among the top collaborators of Weiling Leng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiling Leng. Weiling Leng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Yuling, Weiling Leng, Ying Li, et al.. (2024). Association between serum β2‐microglobulin and left ventricular hypertrophy in patients with type 2 diabetes mellitus: A cross‐sectional study. Journal of Diabetes. 16(8). e13599–e13599. 3 indexed citations
2.
Leng, Weiling, et al.. (2024). Hyperthyroidism crisis and complex pancytopenia: A case report.. PubMed. 49(7). 1089–1094.
3.
Zhang, Yanlin, Liqing Cheng, Yuping Zhang, et al.. (2023). Improving insulin self-injection accuracy in patients with diabetes mellitus through a nursing project. Advances in Clinical and Experimental Medicine. 33(6). 563–572. 2 indexed citations
4.
Zhang, Yulin, Weiling Leng, Liu Chen, et al.. (2022). Sex Differences in Type 2 Diabetes Mellitus-Related Left Ventricular Remodeling: A Cardiovascular Magnetic Resonance Study. Journal of Diabetes Research. 2022. 1–6. 4 indexed citations
5.
Leng, Weiling, et al.. (2021). Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4423–4432. 5 indexed citations
6.
Leng, Weiling, et al.. (2021). Metformin and Malignant Tumors: Not Over the Hill. Diabetes Metabolic Syndrome and Obesity. Volume 14. 3673–3689. 14 indexed citations
7.
Zhang, Yulin, Weiling Leng, Liu Chen, et al.. (2021). Assessment of right ventricular function using cardiovascular magnetic resonance in patients with type 2 diabetes mellitus. Quantitative Imaging in Medicine and Surgery. 12(2). 1539–1548. 1 indexed citations
8.
Wu, Qinan, et al.. (2019). Exenatide reduces cardiomyocyte apoptosis by stimulating adiponectin secretion and activating APPL1-AMPK-PPARα axis. Annals of Translational Medicine. 7(14). 326–326. 11 indexed citations
9.
Leng, Weiling, et al.. (2019). The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus. Annals of Translational Medicine. 7(18). 429–429. 55 indexed citations
10.
Leng, Weiling, et al.. (2019). Lower limb arterial intervention or autologous platelet-rich gel treatment of diabetic lower extremity arterial disease patients with foot ulcers. Annals of Translational Medicine. 7(18). 485–485. 10 indexed citations
11.
Leng, Weiling, et al.. (2019). The Reduced Expression of EOLA1 May Be Related to Refractory Diabetic Foot Ulcer. Mediators of Inflammation. 2019. 1–8. 6 indexed citations
12.
Chen, Liu, Qinan Wu, Mengliu Yang, et al.. (2018). TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes. Journal of Diabetes Research. 2018. 1–13. 4 indexed citations
13.
Zhang, Xiaochun, Weiling Leng, Liu Chen, et al.. (2018). Increased fractal dimension of left ventricular trabeculations is associated with subclinical diastolic dysfunction in patients with type-2 diabetes mellitus. International journal of cardiac imaging. 35(4). 665–673. 17 indexed citations
14.
Leng, Weiling, et al.. (2018). Distribution of Microbes and Drug Susceptibility in Patients with Diabetic Foot Infections in Southwest China. Journal of Diabetes Research. 2018. 1–9. 33 indexed citations
15.
Zhang, Zhihui, et al.. (2017). Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling. Molecular and Cellular Endocrinology. 447. 106–115. 14 indexed citations
16.
Zhang, Xiaochun, et al.. (2017). Left atrium passive ejection fraction is the most sensitive index of type 2 diabetes mellitus-related cardiac changes. International journal of cardiac imaging. 34(1). 141–151. 7 indexed citations
17.
Leng, Weiling, Xinshou Ouyang, Liu Chen, et al.. (2016). The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice. Mediators of Inflammation. 2016. 1–13. 148 indexed citations
18.
Zhang, Xiaochun, Liu Chen, Weiling Leng, et al.. (2016). Assessment of Left Ventricular Structural Remodelling in Patients with Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance. Journal of Diabetes Research. 2016. 1–8. 12 indexed citations
19.
Leng, Weiling, et al.. (2015). EOLA1 Inhibits Lipopolysaccharide-Induced Vascular Cell Adhesion Molecule-1 Expression by Association with MT2A in ECV304 Cells. International Journal of Inflammation. 2015. 1–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026